{"url_path":"/sec/govx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/832489/0001437749-26-017048-index.html","accession_number":"0001437749-26-017048","cik":"0000832489","ticker":"GOVX","issuer_name":"GeoVax Labs, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/832489/0001437749-26-017048-index.html","primary_entity_key":"0000832489","primary_entity_name":"GeoVax Labs, Inc."},"word_count":452,"has_tables":true,"body_markdown":"**Item 6**\n**Exhibits**\n\n \n \n\nExhibit\n \n\nNumber \nDescription\n\n3.2\n\n[Certificate of Amendment to Certificate of Incorporation filed January 9, 2026 (2)](http://www.sec.gov/Archives/edgar/data/832489/000143774926001113/ex_906010.htm)\n\n4.1\n\n[Form of Pre-Funded Warrant, dated February 17, 2026 (3)](http://www.sec.gov/Archives/edgar/data/832489/000143774926004392/ex_921747.htm)\n\n4.2\n\n[Form of Series A-1 Common Warrant, dated February 17, 2026 (3)](http://www.sec.gov/Archives/edgar/data/832489/000143774926004392/ex_921748.htm)\n\n4.3\n\n[Form of Series A-2 Common Warrant, dated February 17, 2026 (3)](http://www.sec.gov/Archives/edgar/data/832489/000143774926004392/ex_921749.htm)\n\n4.4\n\n[Form of Warrant Amendment Agreement, dated February 17, 2026 (3)](http://www.sec.gov/Archives/edgar/data/832489/000143774926004392/ex_921750.htm)\n\n4.5\n\n[Form of Common Stock Purchase Warrant, dated March 31, 2026 (4)](http://www.sec.gov/Archives/edgar/data/832489/000143774926010733/ex_939900.htm)\n\n4.6\n\n[Form of Common Stock Purchase Warrant, dated May 8, 2026 (5)](http://www.sec.gov/Archives/edgar/data/832489/000143774926015613/ex_958825.htm)\n\n10.1\n\n[Securities Purchase Agreement, dated February 12, 2026 (3)](http://www.sec.gov/Archives/edgar/data/832489/000143774926004392/ex_921752.htm)\n\n10.2\n\n[Form of Inducement Letter, dated March 31, 2026 (4)](http://www.sec.gov/Archives/edgar/data/832489/000143774926010733/ex_939901.htm)\n\n10.3\n\n[Form of Inducement Letter, dated May 7, 2026 (5)](http://www.sec.gov/Archives/edgar/data/832489/000143774926015613/ex_958826.htm)\n\n31.1*\n\n[Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934](ex_959642.htm)\n\n31.2*\n\n[Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934](ex_959643.htm)\n\n32.1*\n\n[Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002](ex_959644.htm)\n\n32.2*\n\n[Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002](ex_959645.htm)\n\n101.INS\n\nInline XBRL Instance Document (1)\n\n101.SCH\n\nInline XBRL Taxonomy Extension Schema Document (1)\n\n101.CAL\n\nInline XBRL Taxonomy Extension Calculation Linkbase Document (1)\n\n101.DEF\n\nInline XBRL Taxonomy Extension Definition Linkbase Document (1)\n\n101.LAB\n\nInline XBRL Taxonomy Extension Label Linkbase Document (1)\n\n101.PRE\n\nInline XBRL Taxonomy Extension Presentation Linkbase Document (1)\n\n104\n\nInline XBRL for the cover page of this Quarterly Report on Form 10-Q and included in the Exhibit 101 Inline XBRL Document Set (1)\n\n \n\n \n\n*\n\nFiled herewith\n\n**\n\nIndicates a management contract or compensatory plan or arrangement\n\n \n\n(1)\n\nThese interactive data files shall not be deemed filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under these sections.\n\n(2)\n\nIncorporated by reference from the registrant’s Current Report on Form 8-K filed January 12, 2026.\n\n(3)\n\nIncorporated by reference from the registrant’s Current Report on Form 8-K filed February 17, 2026.\n\n(4)\n\nIncorporated by reference from the registrant’s Current Report on Form 8-K filed March 31, 2026o\n\n(5)\n\nIncorporated by reference from the registrant’s Current Report on Form 8-K filed May 7, 2026o\n\n \n\n17\n\n \n\n \n\n**SIGNATURES**\n\n \n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this quarterly report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \n\nGEOVAX LABS, INC.\n\n \n\n \n \n(Registrant)\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n\nDate:         May 14, 2026\n\nBy:\n\n/s/ Mark W. Reynolds\n\n \n\n \n\n \n\nMark W. Reynolds\n\n \n\n \n\n \n\nChief Financial Officer\n\n \n\n \n \n(duly authorized officer and principal financial officer)\n \n\n \n\n18"}